Martha K Terris

Summary

Affiliation: Stanford University
Country: USA

Publications

  1. ncbi request reprint Application of tissue-marking ink to prostate biopsy specimens
    Martha K Terris
    Department of Urology, Stanford University Medical Center, Stanford, California, USA
    Prostate 50:247-51. 2002
  2. ncbi request reprint Prostate biopsy strategies: past, present, and future
    Martha K Terris
    Section of Urology 112C, Veterans Affairs Palo Alto Health Care System, 3801 Miranda Avenue, Palo Alto, CA 94304, USA
    Urol Clin North Am 29:205-12, xi. 2002
  3. ncbi request reprint Impact of obesity on the utility of preoperative prostate-specific antigen velocity to predict for relapse after prostatectomy: a report from the SEARCH database
    Christopher R King
    Division of Urologic Oncology, Department of Radiation Oncology, Stanford University School of Medicine, Stanford, California 94305 5847, USA
    Urology 69:921-6. 2007
  4. ncbi request reprint Comparison of percentage of total prostate needle biopsy tissue with cancer to percentage of cores with cancer for predicting PSA recurrence after radical prostatectomy: results from the SEARCH database
    Stephen J Freedland
    Department of Urology, University of California, Los Angeles, School of Medicine, 90095 1738, USA
    Urology 61:742-7. 2003
  5. ncbi request reprint Improved clinical staging system combining biopsy laterality and TNM stage for men with T1c and T2 prostate cancer: results from the SEARCH database
    Stephen J Freedland
    Department of Urology, University of California Los Angeles School of Medicine and Department of Surgery, Veterans Administration Greater Los Angeles Healthcare System, Los Angeles, California 90095, USA
    J Urol 169:2129-35. 2003
  6. ncbi request reprint Percent of prostate needle biopsy cores with cancer is significant independent predictor of prostate specific antigen recurrence following radical prostatectomy: results from SEARCH database
    Stephen J Freedland
    Department of Urology, University of California Los Angeles, Department of Surgery, Veterans Affairs Greater Los Angeles Health Care System, Los Angeles, California 90095, USA
    J Urol 169:2136-41. 2003
  7. ncbi request reprint Do younger men have better biochemical outcomes after radical prostatectomy?
    Stephen J Freedland
    Department of Urology, Johns Hopkins School of Medicine, Baltimore, Maryland 21287 2101, USA
    Urology 63:518-22. 2004
  8. ncbi request reprint Racial differences in prognostic value of adult height for biochemical progression following radical prostatectomy
    Stephen J Freedland
    Department of Urology, Johns Hopkins School of Medicine, Baltimore, MD 21287, USA
    Clin Cancer Res 11:7735-42. 2005
  9. ncbi request reprint Should a positive surgical margin following radical prostatectomy be pathological stage T2 or T3? Results from the SEARCH database
    Stephen J Freedland
    Department of Urology, University of California Los Angeles and Department of Surgery, Veterans Affairs Greater Los Angeles Health Care System, Los Angeles, California 90095, USA
    J Urol 169:2142-6. 2003
  10. ncbi request reprint Time trends in biochemical recurrence after radical prostatectomy: results of the SEARCH database
    Stephen J Freedland
    Department of Urology, University of California, Los Angeles, School of Medicine, 90095 1738, USA
    Urology 61:736-41. 2003

Collaborators

Detail Information

Publications68

  1. ncbi request reprint Application of tissue-marking ink to prostate biopsy specimens
    Martha K Terris
    Department of Urology, Stanford University Medical Center, Stanford, California, USA
    Prostate 50:247-51. 2002
    ..We have tried several methods of ink application and combining ink-labeled biopsy specimens into fewer containers with the goal of maintaining information regarding location while minimizing the expense...
  2. ncbi request reprint Prostate biopsy strategies: past, present, and future
    Martha K Terris
    Section of Urology 112C, Veterans Affairs Palo Alto Health Care System, 3801 Miranda Avenue, Palo Alto, CA 94304, USA
    Urol Clin North Am 29:205-12, xi. 2002
    ..The cancer detection rate for transrectal ultrasound-guided prostate biopsies has fallen, and the repeat biopsy rate has risen. The future will most likely see fewer biopsies performed but with wiser guiding systems...
  3. ncbi request reprint Impact of obesity on the utility of preoperative prostate-specific antigen velocity to predict for relapse after prostatectomy: a report from the SEARCH database
    Christopher R King
    Division of Urologic Oncology, Department of Radiation Oncology, Stanford University School of Medicine, Stanford, California 94305 5847, USA
    Urology 69:921-6. 2007
    ....
  4. ncbi request reprint Comparison of percentage of total prostate needle biopsy tissue with cancer to percentage of cores with cancer for predicting PSA recurrence after radical prostatectomy: results from the SEARCH database
    Stephen J Freedland
    Department of Urology, University of California, Los Angeles, School of Medicine, 90095 1738, USA
    Urology 61:742-7. 2003
    ..We compared the total percentage of biopsy tissue with cancer to the percentage of cores positive for their ability to predict adverse pathologic findings and biochemical failure after radical prostatectomy (RP)...
  5. ncbi request reprint Improved clinical staging system combining biopsy laterality and TNM stage for men with T1c and T2 prostate cancer: results from the SEARCH database
    Stephen J Freedland
    Department of Urology, University of California Los Angeles School of Medicine and Department of Surgery, Veterans Administration Greater Los Angeles Healthcare System, Los Angeles, California 90095, USA
    J Urol 169:2129-35. 2003
    ..We determined whether we could improve the prognostic value of the TNM staging system in men with cT1c and cT2 cancers by including information on whether prostate needle biopsy was unilaterally or bilaterally positive...
  6. ncbi request reprint Percent of prostate needle biopsy cores with cancer is significant independent predictor of prostate specific antigen recurrence following radical prostatectomy: results from SEARCH database
    Stephen J Freedland
    Department of Urology, University of California Los Angeles, Department of Surgery, Veterans Affairs Greater Los Angeles Health Care System, Los Angeles, California 90095, USA
    J Urol 169:2136-41. 2003
    ..We evaluate whether either percent of cores with cancer or percent of cores positive from the most and least involved side of the prostate needle biopsy was associated with a worse outcome among men treated with radical prostatectomy...
  7. ncbi request reprint Do younger men have better biochemical outcomes after radical prostatectomy?
    Stephen J Freedland
    Department of Urology, Johns Hopkins School of Medicine, Baltimore, Maryland 21287 2101, USA
    Urology 63:518-22. 2004
    ..Prior studies have suggested that younger men have lower prostate-specific antigen recurrence rates after RP, although none of the prior studies had controlled for the year of surgery...
  8. ncbi request reprint Racial differences in prognostic value of adult height for biochemical progression following radical prostatectomy
    Stephen J Freedland
    Department of Urology, Johns Hopkins School of Medicine, Baltimore, MD 21287, USA
    Clin Cancer Res 11:7735-42. 2005
    ..However, hormonal activity and diets vary between races. We examined whether height was significantly associated with biochemical progression following radical prostatectomy and whether there was an interaction between height and race...
  9. ncbi request reprint Should a positive surgical margin following radical prostatectomy be pathological stage T2 or T3? Results from the SEARCH database
    Stephen J Freedland
    Department of Urology, University of California Los Angeles and Department of Surgery, Veterans Affairs Greater Los Angeles Health Care System, Los Angeles, California 90095, USA
    J Urol 169:2142-6. 2003
    ..We examined the significance of the pathological features of positive surgical margin and extracapsular extension for predicting biochemical failure following radical prostatectomy...
  10. ncbi request reprint Time trends in biochemical recurrence after radical prostatectomy: results of the SEARCH database
    Stephen J Freedland
    Department of Urology, University of California, Los Angeles, School of Medicine, 90095 1738, USA
    Urology 61:736-41. 2003
    ..We also examined whether the biochemical recurrence rates after RP have changed with time...
  11. ncbi request reprint Preoperative model for predicting prostate specific antigen recurrence after radical prostatectomy using percent of biopsy tissue with cancer, biopsy Gleason grade and serum prostate specific antigen
    Stephen J Freedland
    Department of Urology, Johns Hopkins School of Medicine, Baltimore, Maryland 21287, USA
    J Urol 171:2215-20. 2004
    ..We developed a preoperative model to risk stratify patients for prostate specific antigen (PSA) failure following radical prostatectomy (RP) and identify those at high risk who would be potential candidates for neoadjuvant clinical trials...
  12. ncbi request reprint Impact of obesity on biochemical control after radical prostatectomy for clinically localized prostate cancer: a report by the Shared Equal Access Regional Cancer Hospital database study group
    Stephen J Freedland
    Department of Urology, The Johns Hopkins School of Medicine, 600 N Wolfe Street, Baltimore, MD 21287 2101, USA
    J Clin Oncol 22:446-53. 2004
    ..Given the limited information regarding the impact of obesity on treatment outcomes for prostate cancer, we sought to examine the relationship between body mass index (BMI) and cancer control after radical prostatectomy (RP)...
  13. ncbi request reprint Obesity and biochemical outcome following radical prostatectomy for organ confined disease with negative surgical margins
    Stephen J Freedland
    Department of Urology, Johns Hopkins School of Medicine, Baltimore, MD 21287 2101, USA
    J Urol 172:520-4. 2004
    ....
  14. ncbi request reprint Biochemical outcome after radical prostatectomy among men with normal preoperative serum prostate-specific antigen levels
    Stephen J Freedland
    Department of Urology, Johns Hopkins School of Medicine, Baltimore, Maryland 21287 2101, USA
    Cancer 101:748-53. 2004
    ..Whether malignancies in such men are associated with better outcomes is unclear. The authors compared the risk of biochemical failure after radical prostatectomy (RP) between men with normal PSA levels and men with elevated PSA levels...
  15. ncbi request reprint Multiinstitutional validation of the UCSF cancer of the prostate risk assessment for prediction of recurrence after radical prostatectomy
    Matthew R Cooperberg
    Department of Urology, Program in Urologic Oncology, Urologic Outcomes Research Group, UCSF Comprehensive Cancer Center, University of California, San Francisco, California 94143, USA
    Cancer 107:2384-91. 2006
    ..This study used a large external dataset to validate CAPRA...
  16. ncbi request reprint Prostate size and risk of high-grade, advanced prostate cancer and biochemical progression after radical prostatectomy: a search database study
    Stephen J Freedland
    Department of Urology, Johns Hopkins School of Medicine, 600 N Wolfe St, Baltimore, MD 21287 2101, USA
    J Clin Oncol 23:7546-54. 2005
    ..We examined whether prostate weight was associated with tumor grade, advanced disease, or risk of biochemical progression after radical prostatectomy (RP)...
  17. ncbi request reprint Optimal timing, cutoff, and method of calculation of preoperative prostate-specific antigen velocity to predict relapse after prostatectomy: a report from SEARCH
    Christopher R King
    Department of Radiation Oncology, Division of Urologic Oncology, Stanford University School of Medicine, Stanford, California 94305 5847, USA
    Urology 69:732-7. 2007
    ..We studied the timing, cutoff levels, and method of calculation to better define its usefulness...
  18. ncbi request reprint Predictors of prostate-specific antigen progression among men with seminal vesicle invasion at the time of radical prostatectomy
    Stephen J Freedland
    Department of Urology, Johns Hopkins School of Medicine, Baltimore, Maryland 21287, USA
    Cancer 100:1633-8. 2004
    ..The authors examined whether there was a subset of men with SV invasion who had long-term prostate-specific antigen (PSA) progression-free survival...
  19. doi request reprint Freedom from a detectable ultrasensitive prostate-specific antigen at two years after radical prostatectomy predicts a favorable clinical outcome: analysis of the SEARCH database
    Steven L Chang
    Department of Urology, Stanford University Medical Center, Stanford, California 94305, USA
    Urology 75:439-44. 2010
    ..Previous studies demonstrate that a PSADT < 9 months after radical prostatectomy is associated with prostate cancer-specific mortality. Conventionally, PSADT has been calculated after biochemical failure (PSA > or = 2 0.2 ng/mL)...
  20. ncbi request reprint The percentage of prostate needle biopsy cores with carcinoma from the more involved side of the biopsy as a predictor of prostate specific antigen recurrence after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEAR
    Stephen J Freedland
    Department of Urology, University of California Los Angeles, Los Angeles, California, USA
    Cancer 98:2344-50. 2003
    ....
  21. ncbi request reprint Comparison of preoperative prostate specific antigen density and prostate specific antigen for predicting recurrence after radical prostatectomy: results from the search data base
    Stephen J Freedland
    Department of Urology, University of California Los Angeles School of Medicine, USA
    J Urol 169:969-73. 2003
    ..We determined whether preoperative PSA density calculated using transrectal ultrasound prostate volume was a better predictor of advanced pathological findings or biochemical recurrence after radical prostatectomy relative to PSA...
  22. ncbi request reprint Obesity, serum prostate specific antigen and prostate size: implications for prostate cancer detection
    Stephen J Freedland
    Department of Urology, Johns Hopkins School of Medicine, Baltimore, Maryland, USA
    J Urol 175:500-4; discussion 504. 2006
    ..We examined the association between BMI, and PSA and prostate weight in a cohort of men undergoing RP...
  23. ncbi request reprint Delay of radical prostatectomy and risk of biochemical progression in men with low risk prostate cancer
    Stephen J Freedland
    Department of Urology, Johns Hopkins School of Medicine, Baltimore, Maryland, USA
    J Urol 175:1298-302; discussion 1302-3. 2006
    ..Whether delays and especially prolonged delays, eg greater than 180 days, before RP negatively impact the disease outcome is unclear...
  24. doi request reprint Multi-institutional validation of the CAPRA-S score to predict disease recurrence and mortality after radical prostatectomy
    Sanoj Punnen
    Department of Urology, UCSF Comprehensive Cancer Center, University of California, San Francisco, CA, USA
    Eur Urol 65:1171-7. 2014
    ..However, this clinical tool has never been validated externally...
  25. ncbi request reprint Body mass index as a predictor of prostate cancer: development versus detection on biopsy
    Stephen J Freedland
    Department of Urology, Johns Hopkins School of Medicine, Baltimore, Maryland 21287 2101, USA
    Urology 66:108-13. 2005
    ..To determine whether obesity is biologically associated with an increased risk of prostate cancer development, especially aggressive disease and to explore whether a bias may exist in our ability to detect these cancers in obese patients...
  26. pmc Positive surgical margins in radical prostatectomy patients do not predict long-term oncological outcomes: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) cohort
    Prabhakar Mithal
    Department of Urology, University of Rochester Medical Center, Rochester, NY, USA
    BJU Int 117:244-8. 2016
    ..To assess the impact of positive surgical margins (PSMs) on long-term outcomes after radical prostatectomy (RP), including metastasis, castrate-resistant prostate cancer (CRPC), and prostate cancer-specific mortality (PCSM)...
  27. ncbi request reprint Prostate biopsy volume indices do not predict for significant Gleason upgrading
    Christopher R King
    Division of Urologic Oncology, Department of Radiation Oncology, Stanford University School of Medicine, Stanford, California 94305, USA
    Am J Clin Oncol 28:125-9. 2005
    ..This suggests that the correlation that exists between such volume surrogates and outcomes after surgery reflect tumor volume effects only, independently of any possible association between tumor volume and Gleason grade...
  28. doi request reprint Prostate-specific antigen level, stage or Gleason score: which is best for predicting outcomes after radical prostatectomy, and does it vary by the outcome being measured? Results from Shared Equal Access Regional Cancer Hospital database
    Prabhakar Mithal
    Department of Urology, University of Rochester Medical Center, Rochester, New York, USA
    Int J Urol 22:362-6. 2015
    ....
  29. ncbi request reprint Interval from prostate biopsy to radical prostatectomy: effect on PSA, Gleason sum, and risk of recurrence
    Atsuko Shibata
    Department of Health Research and Policy, Stanford University School of Medicine, Stanford, California, USA
    Urology 66:808-13. 2005
    ..To determine whether the change in prostate-specific antigen (PSA), change in Gleason sum, and/or interval between prostate biopsy and radical prostatectomy have an association with biochemical recurrence...
  30. ncbi request reprint Transperineal prostate biopsy after abdominoperineal resection
    Katsuto Shinohara
    Department of Urology, University of California San Francisco and UCSF Mt Zion Comprehensive Cancer Center, San Francisco, CA, USA
    J Urol 169:141-4. 2003
    ..We report our experience with transperineal ultrasound biopsy for evaluating the prostate in patients with elevated PSA who have previously undergone abdominoperineal resection...
  31. ncbi request reprint Lower body mass index is associated with a higher prostate cancer detection rate and less favorable pathological features in a biopsy population
    Joseph C Presti
    Department of Urology, Stanford University School of Medicine, Stanford, California 94305 5118, USA
    J Urol 171:2199-202. 2004
    ..We assessed the relationship between BMI, and prostate cancer detection rates and biopsy features in a referral based biopsy population...
  32. ncbi request reprint Continuous, noninvasive, and localized microvascular tissue oximetry using visible light spectroscopy
    David A Benaron
    Biomedical Optics Laboratory, and Department of Pediatrics, Stanford Hospital and Livermore Veterans Affairs Medical Center, Palo Alto, California 94305, USA
    Anesthesiology 100:1469-75. 2004
    ..Unlike near-infrared spectroscopy or pulse oximetry (SpO2), VLS tissue oximetry uses shallow-penetrating visible light to measure microvascular hemoglobin oxygen saturation (StO2) in small, thin tissue volumes...
  33. ncbi request reprint Luteinizing hormone-releasing hormone agonists and meningioma: a treatment dilemma
    Keith L Lee
    Department of Urology, Stanford University Medical Center, Stanford, California, USA
    Urology 62:351. 2003
    ..These cases also highlight the need for caution against assuming that skull-based intracranial growths in patients receiving hormonal therapy for prostate cancer are metastatic lesions rather than hormonally induced primary tumors...
  34. ncbi request reprint Race as an outcome predictor after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database
    Stephen J Freedland
    Department of Urology, University of California, Los Angeles, School of Medicine, Los Angeles, California 90095 1738, USA
    Urology 60:670-4. 2002
    ....
  35. ncbi request reprint Vasectomy and prostate cancer characteristics of patients referred for prostate biopsy
    Julie A Chacko
    Section of Urology, Veterans Affairs Health Care System, Palo Alto, CA, USA
    J Urol 168:1408-11. 2002
    ..In patients referred for prostate needle biopsies we compared the incidence and characteristics of prostate cancer in those reporting a history of vasectomy to those denying prior vasectomy...
  36. ncbi request reprint Evaluation of fluorodeoxyglucose positron emission tomography imaging in metastatic transitional cell carcinoma with and without prior chemotherapy
    I Jenna Liu
    Section of Urology, Veterans Affairs Palo Alto Health Care System, Palo Alto, Calif, USA
    Urol Int 77:69-75. 2006
    ..This study was designed to determine the value of fluorodeoxyglucose (FDG) positron emission tomography (PET) in the evaluation of metastatic transitional cell carcinoma (TCC)...
  37. ncbi request reprint Association between marijuana use and transitional cell carcinoma
    Julie A Chacko
    Department of Urology, Stanford University Medical Center, Stanford, California, USA
    Urology 67:100-4. 2006
    ....
  38. ncbi request reprint Urinary diversion in the management of chronic perineal skin ulceration in spinal cord injured patients following sphincterotomy
    Moritz Hansen
    Department of Urology, Stanford University, USA
    Adv Exp Med Biol 539:879-84. 2003
    ..Carefully tailored urinary diversion offers an excellent alternative in the spinal cord injured patient with chronic urine leakage and pressure sores following sphincterotomy...
  39. ncbi request reprint Effectiveness of denuding the intestinal mucosa by submucosal injection in the porcine model
    I Jenna Liu
    Section of Urology, Veterans Affairs Palo Alto Health Care System, Palo Alto, California, USA
    Adv Exp Med Biol 539:869-78. 2003
  40. ncbi request reprint Long-term culture of porcine bladder epithelial cells
    Ursula K Ehmann
    Department of Pathology and Laboratory Services, Stanford University Medical Center, California 94305 5118, USA
    In Vitro Cell Dev Biol Anim 38:137-41. 2002
    ..Tight junctions, visualized with an antibody to the ZO1 protein, connected all the cells to their neighbors. Most cells in passage 9 carried the diploid chromosome number of 38...
  41. ncbi request reprint Race, biochemical disease recurrence, and prostate-specific antigen doubling time after radical prostatectomy: results from the SEARCH database
    Robert J Hamilton
    Division of Urologic Surgery, Department of Surgery, Duke University School of Medicine, Durham, North Carolina 27710, USA
    Cancer 110:2202-9. 2007
    ..To address this issue, the authors examined racial differences in pathologic features, time to disease recurrence, and prostate-specific antigen (PSA) doubling time (PSADT) among a cohort of patients treated with RP...
  42. ncbi request reprint High yield of saturation prostate biopsy for patients with previous negative biopsies and small prostates
    Kamran P Sajadi
    Section of Urology, Department of Surgery, Medical College of Georgia, Augusta, Georgia 30912 4050, USA
    Urology 70:691-5. 2007
    ..We sought to determine the patient characteristics for which repeat biopsy by SPB provides the greatest utility for prostate cancer detection...
  43. ncbi request reprint Is a positive bladder neck margin truly a T4 lesion in the prostate specific antigen era? Results from the SEARCH Database
    W Cooper Buschemeyer
    Department of Surgery Division of Urologic Surgery, Duke University School of Medicine and Urology Section, Surgical Service, Veterans Affairs Medical Center Durham, Durham, North Carolina 27710, USA
    J Urol 179:124-9; discussion 129. 2008
    ..We examined the association between positive bladder neck margins and prostate specific antigen recurrence relative to other pathological findings...
  44. ncbi request reprint Obesity-related plasma hemodilution and PSA concentration among men with prostate cancer
    Lionel L Banez
    Division of Urologic Surgery and the Duke Prostate Center, and Department of Surgery, Duke University Medical Center, Durham, NC 27710, USA
    JAMA 298:2275-80. 2007
    ..Because men with higher body mass index (BMI) have greater circulating plasma volumes, lower PSA concentrations among obese men may be due to hemodilution...
  45. ncbi request reprint PSA in the new millennium: a powerful predictor of prostate cancer prognosis and radical prostatectomy outcomes--results from the SEARCH database
    Stephen J Freedland
    Urology Section, Veterans Affairs Medical Center, Durham, NC, USA
    Eur Urol 53:758-64; discussion 765-6. 2008
    ..We examined the prognostic significance of preoperative PSA to predict pathologic stage and biochemical progression among men undergoing radical prostatectomy in the new millennium (2000-2006)...
  46. pmc What are the factors associated with short prostate specific antigen doubling time after radical prostatectomy? A report from the SEARCH database group
    Anna E Teeter
    Division of Urologic Surgery and Duke Prostate Center, Department of Surgery, Duke University Medical Center, Durham, North Carolina 27710, USA
    J Urol 180:1980-4; discussion 1985. 2008
    ..We determined which demographic and clinicopathological variables were predictive of a short prostate specific antigen doubling time in a cohort of men with clinically localized prostate cancer treated with radical prostatectomy...
  47. ncbi request reprint Small transrectal ultrasound volume predicts clinically significant Gleason score upgrading after radical prostatectomy: results from the SEARCH database
    Ryan S Turley
    Division of Urological Surgery, Duke Prostate Center, Duke University School of Medicine, Durham, North Carolina, USA
    J Urol 179:523-7; discussion 527-8. 2008
    ..We examined the likelihood of clinically relevant upgrading after radical prostatectomy as a function of transrectal ultrasound volume...
  48. doi request reprint The effect of race/ethnicity on the accuracy of the 2001 Partin Tables for predicting pathologic stage of localized prostate cancer
    Elisabeth I Heath
    Barbara Ann Karmanos Cancer Institute, Department of Hematology and Oncology, Wayne State University, 4100 John R, 4 HWCRC, Detroit, MI 48201, USA
    Urology 71:151-5. 2008
    ..To test the accuracy of the 2001 Partin Tables in African American men who underwent radical prostatectomy at multiple centers throughout the United States...
  49. pmc Risk stratification for biochemical recurrence in men with positive surgical margins or extracapsular disease after radical prostatectomy: results from the SEARCH database
    Jayakrishnan Jayachandran
    Division of Urologic Surgery, Department of Surgery, Duke University School of Medicine, Durham, North Carolina 27710, USA
    J Urol 179:1791-6; discussion 1796. 2008
    ..We further stratified these men into a low risk group in which watchful waiting after surgery may be preferred and a high risk cohort in which adjuvant therapy may be preferred...
  50. pmc Limitations of prostate specific antigen doubling time following biochemical recurrence after radical prostatectomy: results from the SEARCH database
    Robert J Hamilton
    Division of Urologic Surgery, Department of Surgery, Duke University School of Medicine, Durham, North Carolina 27710, USA
    J Urol 179:1785-9; discussion 1789-90. 2008
    ..Hence, those with calculable prostate specific antigen doubling time may represent a select lower risk group relative to all men with biochemical recurrence...
  51. pmc Obesity and positive surgical margins by anatomic location after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital database
    Jayakrishnan Jayachandran
    Urology Section, Veterans Affairs Medical Center, Duke University School of Medicine, Durham, NC 27710, USA
    BJU Int 102:964-8. 2008
    ....
  52. doi request reprint Obesity and oncological outcome after radical prostatectomy: impact of prostate-specific antigen-based prostate cancer screening: results from the Shared Equal Access Regional Cancer Hospital and Duke Prostate Center databases
    Stephen J Freedland
    Urology Section, Department of Surgery, Veterans Affairs Medical Center, Duke University Medical Center, Durham, NC 27710, USA
    BJU Int 102:969-74. 2008
    ....
  53. pmc Risk stratification of men with Gleason score 7 to 10 tumors by primary and secondary Gleason score: results from the SEARCH database
    David E Kang
    Division of Urologic Surgery, Department of Surgery and Duke Prostate Center, Duke University School of Medicine, Durham, North Carolina, USA
    Urology 70:277-82. 2007
    ..Whether the increased risk associated with Gleason score 4+3 disease is equivalent to that of Gleason score 4+4 or greater is unclear...
  54. ncbi request reprint Is biopsy Gleason score independently associated with biochemical progression following radical prostatectomy after adjusting for pathological Gleason score?
    Nicholas J Fitzsimons
    Division of Urologic Surgery, Duke Prostate Center, University Medical Center, Duke University School of Medicine, Durham, NC 27710, USA
    J Urol 176:2453-8; discussion 2458. 2006
    ..However, it is unclear whether it remains associated with outcome after surgery when the pathological Gleason score is known...
  55. ncbi request reprint Prostate cancer diagnosed in spinal cord-injured patients is more commonly advanced stage than in able-bodied patients
    Paul A Scott
    Section of Urology, Medical College of Georgia, Augusta, Georgia 30912 4050, USA
    Urology 63:509-12. 2004
    ..Little is known about the characteristics of prostate cancer in men with SCI, because prostate cancer screening is not aggressively performed in this population...
  56. ncbi request reprint Clinical and pathologic outcome after radical prostatectomy for prostate cancer patients with a preoperative Gleason sum of 8 to 10
    Patrick J Bastian
    James Buchanan Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    Cancer 107:1265-72. 2006
    ....
  57. pmc Upgrading and downgrading of prostate needle biopsy specimens: risk factors and clinical implications
    Stephen J Freedland
    Department of Surgery, Durham Veterans Affairs Medical Center, Durham, North Carolina, USA
    Urology 69:495-9. 2007
    ..Given the critical role that needle biopsy plays in treatment decisions, we sought to determine the risk factors for upgrading and downgrading the prostate biopsy specimen...
  58. ncbi request reprint Facing a prostate cancer diagnosis: who is at risk for increased distress?
    Ruben E Perczek
    University of Miami School of Medicine and Geriatric Research, Education, and Clinical Center, VA Medical Center, Miami, Florida 33125, USA
    Cancer 94:2923-9. 2002
    ..This study's purpose was to determine whether differences in distress levels can be attributed to differences in diagnostic status, optimism, and/or coping strategies...
  59. ncbi request reprint Body mass index, prostate weight and transrectal ultrasound prostate volume accuracy
    Kamran P Sajadi
    Augusta Veterans Affairs Medical Center and Medical College of Georgia, Augusta, Georgia 30912, USA
    J Urol 178:990-5. 2007
    ..We hypothesized that obesity may represent a technical challenge when performing transrectal ultrasound that decreases the accuracy of estimating prostate volume...
  60. ncbi request reprint Predicting unilateral prostate cancer based on biopsy features: implications for focal ablative therapy--results from the SEARCH database
    Charles D Scales
    Department of Surgery Division of Urologic Surgery, Duke University School of Medicine, Durham, North Carolina 27710, USA
    J Urol 178:1249-52. 2007
    ..However, few studies have assessed the correlation between biopsy parameters and pathological outcome (unilateral vs bilateral disease)...
  61. ncbi request reprint Primary care providers' attitudes toward prostate cancer risk factors at a Veterans Affairs health care facility
    Peter A Ruff
    Section of Urology, Medical College of Georgia, Augusta, GA 30904, USA
    Mil Med 170:154-7. 2005
    ..We asked what factors influence primary care providers' decision to screen patients for prostate cancer...
  62. ncbi request reprint Re: Aromatase inhibitors for male infertility
    Martha K Terris
    J Urol 168:1509. 2002
  63. ncbi request reprint Assessment of patient concern and adequacy of informed consent regarding infertility resulting from prostate cancer treatment
    Buffi G Boyd
    Section of Urology, Medical College of Georgia, Augusta, Georgia 30912 4050, USA
    Urology 68:840-4. 2006
    ..A secondary aim was to assess the rate at which men were informed of the fertility implications of prostate cancer treatment by their physician before their selection of a treatment option...
  64. ncbi request reprint Flutamide administration at 500 mg daily has similar effects on serum testosterone to 750 mg daily
    Jeremiah C Murphy
    Section of Urology, Medical College of Georgia, Augusta, 30912, USA
    J Androl 25:630-4. 2004
    ..047). Flutamide at 500 mg did not result in significant changes in testosterone, PSA, prostate volume, or androgen deficiency symptoms compared to 750 mg daily after 3 months...
  65. doi request reprint Effect of advanced age on the development of complications from intravesical bacillus Calmette-Guérin therapy
    Jared G Heiner
    Sections of Urology, Augusta Veterans Affairs Medical Center and Medical College of Georgia, Augusta, GA 30912, USA
    Urol Oncol 26:137-40. 2008
    ..Advanced age is considered a risk factor for complications in patients receiving intravesical bacillus Calmette-Guérin (BCG) therapy. However, there is no clear delineation of BCG-related complication rates relative to patient age...
  66. ncbi request reprint Changing nature of high risk patients undergoing radical prostatectomy
    Christopher J Kane
    Urology Section, Department of Surgery, Veterans Administration Medical Center San Francisco, San Francisco, USA
    J Urol 177:113-7. 2007
    ..We examined the outcomes of radical prostatectomy alone in high risk patients with prostate cancer and evaluated changes in high risk prostate cancer outcomes with time...
  67. pmc Do racial differences in prostate size explain higher serum prostate-specific antigen concentrations among black men?
    John C Mavropoulos
    Department of Pathology, Duke University School of Medicine, Durham, North Carolina 27710, USA
    Urology 69:1138-42. 2007
    ..To determine whether elevated serum prostate-specific antigen (PSA) values in black men are due, at least partially, to larger prostate size among black men...
  68. ncbi request reprint Re: Transrectal ultrasound guided biopsy of the prostate. Do enemas decrease clinically significant complications?
    Martha K Terris
    J Urol 167:2145-6; author reply 2146. 2002